期刊文献+

国产酒石酸托特罗定片治疗膀胱过度活动症的临床研究 被引量:7

A Clinical Study of Domestic Tolterodine Tartrate Tablets for Urinary Bladder Hyperactivity
下载PDF
导出
摘要 目的 :研究国产酒石酸托特罗定片治疗膀胱过度活动症的疗效和安全性。方法 :选择膀胱过度活动症56例 ,随机分为托特罗定组和奥昔布宁组各28例 ,疗程6周。结果 :托特罗定片和奥昔布宁片治疗膀胱过度活动症疗效相当 ,前者的不良反应发生率低于后者。结论 OBJECTIVE:To study the therapeutic effect and safety of domestic tolterodine tartrate in treating patients with urinary bladder overactivity.METHODS:56 cases of bladder overactivity were divided into two groups randomly:tolterodine and control(oxybutynin)group.The course of treatment was 6 weeks.RESULTS:The effect of tolterodine in treatment group was comparable to that of oxybutynin in control group,however,the adverse reactions in oxybutynin group were more common than those in tolterodine group.CONCLUSION:Tolterodine is a suitable drug to treat bladder overactivity.
出处 《中国药房》 CAS CSCD 2001年第2期104-105,共2页 China Pharmacy
关键词 托特罗定 膀胱过度活动症 临床研究 治疗 tolterodine urinary bladder hyperactivity clinical study
  • 相关文献

参考文献1

  • 1郭应禄 沈绍基.现代泌尿外科治疗手册(第1版)[M].北京:北京医科大学,中国协和医科大学联合出版社,1998.178-179.

同被引文献54

  • 1胡悦育,胡兴越.A型肉毒毒素治疗偏头痛的临床研究[J].中国新药与临床杂志,2005,24(2):165-168. 被引量:16
  • 2刘增玉,于秀浚,张晓.A型肉毒杆菌毒素治疗睑痉挛的病理与临床研究[J].中国实用眼科杂志,1996,14(3):172-175. 被引量:19
  • 3王景阳,黄淑云,张增均.酒石酸托特罗定的合成研究[J].天津药学,2006,18(5):71-73. 被引量:3
  • 4Messelink EJ .Treatment of the overactive bladder with toherodine, a new muscarinic receptor antagonist[J] . Br J Urol Int , 1999,83(Suppl 2);48.
  • 5国家药品监督管理局.酒石酸托特罗定胶囊标准(试行)[S].WS515(X-447)-2000.
  • 6CHANCELLOR M, FREEDMAN S, MITCHESON HD, et al. Tolerodine, an effective and well tolerated treatment for urge incontinence and oberactive bladder symptoms[J]. Clin Drag Invest, 2000, 19(2): 83-91.
  • 7ABRAM S P, FREEDMAN R, ANDERSTROM C, et al. Tolterodine, a new antimuscarinic agent: as effective but better than oxybutynin in patients wiih an overactive bladder [J]. Br J Urol, 1998, 81: 801-810.
  • 8NILVEBRANT L, GILLBERG PG, SPARF B. Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine[J]. Pharmacol Toxicol, 1997, 81: 169-172.
  • 9NILVEBRANT L, ANDERSSON KE, GILLBERG PG. Toherodine-a new bladder selective antimuscarinic agent[J]. Eur J Pharmacol, 1997, 327: 195-207.
  • 10ABRAMS P, EARSEON G, CHAPPLE C, et al. Factors involved in the success of antimuscarintc treatment [J]. BJU Int, 1993, 83(Suppl): 42-47.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部